Botanix Pharmaceuticals (BOT) has had its application to use the novel sofpironium bromide gel to treat primary axillary hyperhidrosis rejected by the US Food and Drug Administration (FDA).Source:
https://themarketherald.com.au/botanix-pharmaceuticals-asxbot-suffers-setback-in-fda-approval-for-sofpironium-bromide-gel-to-treat-hyperhidrosis-2023-09-26/
there is no guarantee that by mid 2024 it will be given the approval and it may well get rejected again if the management stuffs up again .
It is up to people what they choose to believe.
Many will always tell you to BUY
Some will always tell you to SELL
but then we have a very few who will do both as per what the market and the smart money is telling them.
Make your investment decisions wisely and always DYOR.
Bot Chart, page-10603
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.005(1.82%) |
Mkt cap ! $441.0M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.0¢ | 27.5¢ | $1.247M | 4.402M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 684251 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 210000 | 8 |
View Market Depth
| Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.3¢ |
Change
0.005 ( 3.10 %) |
||||
| Open | High | Low | Volume | ||
| 27.5¢ | 29.0¢ | 27.5¢ | 1730488 | ||
| Last updated 15.58pm 13/05/2024 ? | |||||
| BOT (ASX) Chart |